Aier Eye Hospital

Aier Eye Hospital Group is an ophthalmic medical group with hospital scale and high-quality medical capabilities in China and globally, with services covering Asia, Europe, and North America. It has three listed companies in Mainland China, Europe, and Southeast Asia (China A-share: Aier Eye Hospital, 300015; Spain: CBAV; Singapore: 40T). Currently, it operates 723 ophthalmic hospitals and centers worldwide, including 610 in Mainland China, 7 in Hong Kong, 1 in the United States, 93 in Europe, and 12 in Southeast Asia. In 2021, the annual outpatient visits in Mainland China exceeded 15 million, with over 1 million surgeries performed, and the medical service network covers nearly 3 billion people globally.
Scientific research innovation and talent cultivation are the cornerstones of long-term development. Aier Eye Hospital continuously increases investment in scientific research, strongly supports frontier and original ophthalmic academic research, and fully promotes the global platform-driven eye health ecosystem strategy. Since 2013, when Aier Eye Hospital and Central South University jointly established the Central South University Aier Eye Hospital College, marking the beginning of innovative school-enterprise cooperation, Aier has successively promoted strategic cooperation with renowned universities such as Hubei University of Science and Technology, Wuhan University, Jinan University, Anhui Medical University, Tianjin University, and Sichuan University. Leveraging the unique advantages of both enterprises and universities, Aier has engaged in in-depth cooperation in hospital co-construction, talent cultivation, faculty development, teaching and research, jointly building an ophthalmic education, research, and medical platform, creating a model of "prestigious university + renowned enterprise," and contributing wisdom and strength to the innovative development of Chinese ophthalmology and visual science.
Aier Eye Hospital has been rated by authoritative institutions for many consecutive years as "one of the top ten listed companies most respected by investors in China," has won the "Huapu Award" at the China Brand Festival, and has received numerous honors such as the "Sustained Investment Value Award," "China Listed Company Shareholder Return Award," and "China Listed Company Industrial Contribution Grand Award." It has also been successfully included in the CSI 300 Index and the MSCI China Large Cap Index constituent stocks.